Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Retained Earnings (2018 - 2025)

Historic Retained Earnings for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to -$295.4 million.

  • Dna X's Retained Earnings fell 1274.23% to -$295.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$295.4 million, marking a year-over-year decrease of 1274.23%. This contributed to the annual value of -$283.6 million for FY2024, which is 1346.14% down from last year.
  • Latest data reveals that Dna X reported Retained Earnings of -$295.4 million as of Q3 2025, which was down 1274.23% from -$290.6 million recorded in Q2 2025.
  • In the past 5 years, Dna X's Retained Earnings registered a high of -$205.5 million during Q1 2021, and its lowest value of -$295.4 million during Q3 2025.
  • For the 5-year period, Dna X's Retained Earnings averaged around -$252.0 million, with its median value being -$249.6 million (2023).
  • Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 1968.98% in 2021, then increased by 8.92% in 2023.
  • Over the past 5 years, Dna X's Retained Earnings (Quarter) stood at -$234.8 million in 2021, then fell by 6.42% to -$249.9 million in 2022, then decreased by 0.04% to -$250.0 million in 2023, then dropped by 13.46% to -$283.6 million in 2024, then dropped by 4.15% to -$295.4 million in 2025.
  • Its Retained Earnings was -$295.4 million in Q3 2025, compared to -$290.6 million in Q2 2025 and -$283.2 million in Q1 2025.